- Research works
- 10 ◆ 1% vs 2018-21
- Citations
- 124 12.4 per fractional work
- Top-10% rate
- 0.0% all institutions 10.0%
- Open access
- 69% world 40%
- International
- 30% world 18%
Not ranked overall: GeneFirst (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does GeneFirst (United Kingdom) work in?
In all years, 50% of research at GeneFirst (United Kingdom) is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (29%), Social Sciences (7%). It does 1.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 10 fields, with their numbers
- Life Sciences550.2%
- Health Sciences332.6%
- Medicine329.3%
- Health Professions03.3%
- Social Sciences110.0%
- Social Sciences16.7%
- Arts and Humanities03.3%
- Physical Sciences17.2%
- Physics and Astronomy05.0%
- Engineering01.1%
- Environmental Science01.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does GeneFirst (United Kingdom) publish most on?
By volume in 2022-now: Cervical Cancer and HPV Research, Epigenetics and DNA Methylation, Relativity and Gravitational Theory and Cosmology and Gravitation Theories.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cervical Cancer and HPV Research Epidemiology 0 works
- 2 Epigenetics and DNA Methylation Molecular Biology 0 works
- 3 Relativity and Gravitational Theory Astronomy and Astrophysics 0 works
- 4 Cosmology and Gravitation Theories Astronomy and Astrophysics 0 works
- 5 Pluripotent Stem Cells Research Molecular Biology 0 works
- 6 Genomics and Chromatin Dynamics Molecular Biology 0 works
- 7 Black Holes and Theoretical Physics Nuclear and High Energy Physics 0 works
- 8 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 10 Biosensors and Analytical Detection Biomedical Engineering 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has GeneFirst (United Kingdom)'s research output changed?
Output in 2022-2025 was 1% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is GeneFirst (United Kingdom) as a percentage of every work published that year, 0.0000093% in 2023.
Fractional works of GeneFirst (United Kingdom) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Abingdon
- United Kingdom Atomic Energy Authority
- Culham Science Centre
- Oxford Instruments (United Kingdom)
- Evotec (United Kingdom)
- Summit (United Kingdom)
- Immunocore (United Kingdom)
- Tokamak Energy (United Kingdom)
- Adaptimmune (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about GeneFirst (United Kingdom). Posts are plain text and can be reported.